UC San Diego Joins Second Major National Clinical Trial for Novel Coronavirus

UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.

Read more

Is COVID-19 Transmitted Through Breast Milk? Study Suggests Not Likely

A recent study by researchers at University of California San Diego School of Medicine suggests transmission of COVID-19 through breast milk is not likely. The infectious virus was not detected in 64 samples of breast milk tested.

Read more

Imitation May Be a Sincere Form of Treatment

The National Institutes of Health will soon launch a phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.

Read more

Abated Breath: From COVID-19 to Wildfire Smoke and Air Pollution, Multiple Factors Threaten Lung Health This Summer

As we continue to grapple with the global pandemic, rising summer temperatures and wildfire season pose new challenges to our

Read more

Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus?

Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.

Read more

X-rays size up protein structure at the ‘heart’ of COVID-19 virus

Researchers have performed the first room temperature X-ray measurements on the SARS-CoV-2 main protease—the enzyme that enables the virus to reproduce. It marks an important first step in the ultimate goal of building a comprehensive 3D model of the enzymatic protein that will be used to advance supercomputing simulations aimed at finding drug inhibitors to block the virus’s replication mechanism and help end the COVID-19 pandemic.

Read more

Researchers Develop First Model to Predict Likelihood of Testing Positive for COVID-19 and Outcomes from the Disease

Cleveland Clinic researchers have developed the world’s first risk prediction model for healthcare providers to forecast an individual patient’s likelihood of testing positive for COVID-19 as well as their outcomes from the disease.

According a new study published in CHEST, the risk prediction model (called a nomogram) shows the relevance of age, race, gender, socioeconomic status, vaccination history and current medications in COVID-19 risk.

Read more

“Prescribing Art” course teaches med students to recognize bias and better address racial disparities

Can art help doctors better understand their patients and address racial disparities? An innovative collaboration at the University of Alabama at Birmingham uses art to help medical students hone their observational skills, in order to make more accurate diagnoses. “Prescribing Art: How Observation Enhances Medicine” is a partnership between the School of Medicine, the Abroms-Engel Institute for Visual Arts and the Birmingham Civil Rights Institute.

Read more